Cue Biopharma, Inc.
CUE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645460
In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Cue Biopharma, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 49 | 47 | −2 |
| Shares | 11.4M | 17.4M | +5.95M (+52.2%) |
| Value | $10.4M | $11.9M | +$1.48M (+14.3%) |
New holders (8)
Institutions that held Cue Biopharma, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Catalytic Wealth RIA, LLC | 3,331,644 | $2.27M | 0.19% |
| Susquehanna International Group, LLP | 154,243 | $105.2K | 0.00% |
| Angeles Wealth Management, LLC | 120,000 | $81.9K | 0.01% |
| Virtu Financial LLC | 20,667 | $14.0K | 0.00% |
| Prevail Innovative Wealth Advisors, LLC | 18,987 | $13.0K | 0.00% |
| Salzhauer Michael | 16,000 | $10.9K | 0.01% |
| HRT Financial LP | 11,812 | $8.00K | 0.00% |
| Raymond James Financial Inc | 3,350 | $2.29K | 0.00% |
Sold out (10)
Institutions that held Cue Biopharma, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| HighTower Advisors, LLC | 128,284 | $116.9K |
| Gsa Capital Partners LLP | 117,262 | $107.0K |
| Squarepoint Ops LLC | 34,778 | $31.7K |
| StoneX Group Inc. | 14,058 | $12.8K |
| Group One Trading, L.P. | 13,572 | $12.4K |
| Two Sigma Securities, LLC | 10,390 | $9.46K |
| Tower Research Capital LLC (TRC) | 3,874 | $3.53K |
| Simplex Trading, LLC | 2,395 | $2.00K |
| Mather Group, LLC. | 1,000 | $911 |
| Stonebridge Financial Group, LLC | 62 | $56 |